Cargando...
Case report: Patiromer-induced hypercalcemia
Patiromer is a novel potassium-binding compound which has recently received FDA approval. This ion exchange resin releases calcium when it binds potassium. We describe the development of hypercalcemia after initiation of patiromer. The calcium levels fell when the drug was stopped but recurred when...
Gardado en:
| Publicado en: | Clin Nephrol Case Stud |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dustri-Verlag Dr. Karl Feistle
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691394/ https://ncbi.nlm.nih.gov/pubmed/31410346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS109782 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|